ARC Fertility

12/24/2025

This season is about hope, connection and the families we’re building together. From all of us at ARC Fertility, we’re wishing you comfort, joy and moments that remind you how supported you truly are, today and always.

12/22/2025

ARC Fertility’s Inclusive Menopause Benefit Offering supports employees navigating menopause and perimenopause with personalized care, symptom management, mental health support and flexible virtual or in-person consultations.

Employers can enhance well-being, productivity and workplace inclusion by providing access to top specialists and high-quality resources. Our comprehensive approach ensures women receive the care they need while fostering a healthier, more engaged workforce. Learn more: https://www.arcfertility.com/menopause/

ARC’s Inclusive Menopause Benefit Offering  A key component of ARC Fertility’s commitment to providing comprehensive family-forming and reproductive

12/18/2025

Pregnancy loss is a deeply personal journey, and no one should navigate it alone. ARC Fertility provides compassionate, expert-guided support to help individuals and families heal, emotionally, physically and mentally.

With Care Navigators and personalized treatment plans as well as emotional wellness resources, our team meets you where you are, at your pace. Wherever you are on your healing path, ARC Fertility is here for you. Support, clarity and hope can make a meaningful difference today. Learn more: https://www.arcfertility.com/helping-you-navigate-life-after-pregnancy-loss/

Pregnancy loss—whether through miscarriage, stillbirth or infant loss—is a deeply personaland profound experience. It can bring emotional, physical and mental challenges that affectevery aspect of life. ARC Fertility is here to provide compassionate, expert-guided support tohelp you through this...

12/12/2025

We’re proud to share that David Adamson, CEO, ARC Fertility, served on the World Health Organization (WHO) External Review Group for its first-ever global guideline on infertility.

The guideline calls for safer, fairer and more affordable fertility care worldwide, offering 40 evidence-based recommendations on prevention, diagnosis and treatment. Infertility affects 1 in 6 people of reproductive age, yet access remains limited. David’s work supports equitable, patient-centered fertility care across the globe. Learn more: https://www.who.int/news/item/28-11-2025-who-issues-first-global-guideline-on-infertility

12/11/2025

Recently featured in the Self-Insurer, David Adamson, CEO, ARC Fertility, notes that GLP-1 medications are highly effective for many people, and when combined with lifestyle and wellness programs, they can support sustainable weight management.

Maintaining a healthy weight is beneficial for overall health and can also improve fertility outcomes. With the right support, many individuals can eventually taper off GLP-1s while preserving long-term benefits. Read the full article starting on page 4 here: https://issuu.com/selfinsurer/docs/the_self-insurer_digital_edition_for_december_2025

Welcome to Issuu’s blog: home to product news, tips, resources, interviews (and more) related to content marketing and publishing.

12/01/2025

ARC Fertility is proud to receive a Bronze Digital Health Award for excellence in telehealth and remote patient monitoring. Our collaboration with Mira delivers real-time hormone insights, AI-powered tracking and seamless support, helping individuals and employers navigate fertility journeys with greater clarity and confidence.

This recognition reinforces ARC’s commitment to patient-centered digital innovation and the future of connected fertility care. Read more: https://www.arcfertility.com/arc-fertility-earns-bronze-digital-health-award-for-telehealth-and-remote-patient-monitoring/

ARC Fertility wins a Bronze Digital Health Award for Connected Digital Health Telehealth and Remote Patient Monitoring, recognizing leadership in digital fertility care.

11/27/2025

This Thanksgiving, we’re grateful for the families we’ve supported, the providers we partner with and the hope that guides every journey. Wishing our community warmth, connection and moments of joy this holiday season. Happy Thanksgiving from all of us at ARC Fertility.

11/20/2025

David Adamson, CEO, ARC Fertility, recently highlighted in the Journal of Compensation and Benefits that postpartum mental health is a critical workplace priority.

Rising rates of depression and limited access to care leave many new parents struggling after leave ends. Employers that extend support into the postpartum year with mental health care, coaching and flexible reintegration strengthen retention, wellbeing and performance. Read the full article here: https://www.arcfertility.com/addressing-postpartum-health-why-employers-must-recognize-maternal-mental-wellness-as-a-workplace-priority/

Postpartum mental health conditions, including depression, anxiety, and mood disorders, affect one in five mothers in the United States. Men can also experience postpartum depression (PPD), also known as paternal postnatal depression (PPND). These issues are common, yet they remain underdiagnosed, u...

11/18/2025

Rural maternity care is facing a worsening crisis as labor and delivery closures climb nationwide. With more hospitals shutting these units in 2025, families in rural communities are forced to travel longer distances for essential care, increasing risks for mothers and infants.

At ARC Fertility, we believe every family deserves equitable access to high-quality reproductive care, no matter their ZIP code. Learn more: https://www.fiercehealthcare.com/providers/rural-hospitals-labor-and-delivery-closures-increased-2025

More rural hospitals have closed or are planning to close their labor and delivery units in 2025 than in 2024, bringing the total number of closures since the end of 2020 to 116, according to the C | A recent report tallied 27 completed or planned labor and delivery unit closures in 2025 among hospi...

11/14/2025

David Adamson, CEO, ARC Fertility, was recently featured in The Journal of Compensation and Benefits discussing why genetic testing during IVF, especially PGT-A, deserves a place in today’s family-forming benefit strategies.

His latest article outlines how targeted genetic screening can improve outcomes, support eSET and enhance the value of employer-sponsored fertility benefits. Read the full article here: https://www.arcfertility.com/genetic-testing-during-ivf-can-improve-pregnancy-outcomes-deserves-inclusion-in-family-forming-strategy/

Preimplantation Genetic Testing for Aneuploidy (PGT-A) helps identify chromosomally normal embryos during IVF. In selected patients, generally those who are older with a higher probability of abnormal chromosomes and who have several or more embryos, this can improve the chance of pregnancy with the...

11/12/2025

New research in The Lancet Obstetrics, Gynaecology, & Women’s Health calls for national action on endometriosis, and ARC Fertility is proud to spotlight this landmark work.

Led by global experts and supported by International Federation of Fertility Societies (IFFS) and the International Committee for Monitoring Assisted Reproductive Technologies (ICMART), the studies reveal major policy gaps and urge coordinated responses to improve diagnosis and care. As Dr. David Adamson notes, “Endometriosis must be recognized as a chronic condition requiring coordinated national responses.” Learn more: https://www.globenewswire.com/news-release/2025/11/12/3186454/0/en/ARC-Fertility-Highlights-Landmark-Global-Studies-Published-in-The-Lancet-Calling-for-National-Action-on-Endometriosis.html

ARC Fertility Highlights Landmark Global Studies Published in The Lancet Calling for National Action on Endometriosis...

11/11/2025

The FDA’s decision to remove black box warnings from hormone therapy reflects a long-awaited shift toward evidence-based, individualized care for women in menopause. This update acknowledges the real benefits these therapies can provide for heart, brain, bone health and quality of life.

At ARC Fertility, we support informed choices and access to care across every stage of reproductive health. Learn more: https://www.statnews.com/2025/11/10/fda-reverses-hormone-warning-menopause-health/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_Afe3eJ2CecJv-JIzafLaGCvipAXpvBcCayhKCdCjtC334PlkDvnUOQFY2baKvAa8xQrItgDUxHthfBoEjNMfupKsrTA&_hsmi=389313604&utm_content=389313604&utm_source=hs_email

The FDA is reversing a 2003 decision that put a stringent warning on hormone therapy products for menopausal women, saying that the treatments offer heart, brain, and bone health benefits.